These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22043333)

  • 1. Tissue Factor, Tissue Factor Pathway Inhibitor and Factor VII Activity in Cardiovascular Complicated Type 2 Diabetes Mellitus.
    El-Hagracy RS; Kamal GM; Sabry IM; Saad AA; Abou El Ezz NF; Nasr HA
    Oman Med J; 2010 Jul; 25(3):173-8. PubMed ID: 22043333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
    El-Ghoroury EA; El-Din HG; Abdel-Kader M; Ragab S
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):7-13. PubMed ID: 18180609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.
    Vambergue A; Rugeri L; Gaveriaux V; Devos P; Martin A; Fermon C; Fontaine P; Jude B
    Thromb Res; 2001 Mar; 101(5):367-75. PubMed ID: 11297753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D; Bara L; Basdevant A; Samama MM
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.
    Crawley J; Lupu F; Westmuckett AD; Severs NJ; Kakkar VV; Lupu C
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1362-73. PubMed ID: 10807755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
    Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC
    J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
    Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
    J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.
    Mercier E; Branger B; Vecina F; Al-Sabadani B; Berlan J; Dauzat M; Fourcade J; Gris JC
    Hematol J; 2001; 2(1):18-25. PubMed ID: 11920229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte tissue factor response is decreased in patients with hyperlipidemia.
    Rugeri L; Susen S; Bard JM; Corseaux D; Gavériaux V; Devos P; Lecerf JM; Duriez P; Jude B
    Thromb Res; 1999 Nov; 96(4):283-92. PubMed ID: 10593431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
    Thiec F; Cherel G; Christophe OD
    J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor.
    Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L
    J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct inhibition of factor VIIa by TFPI and TFPI constructs.
    Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
    J Thromb Haemost; 2013 Apr; 11(4):704-14. PubMed ID: 23347185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.
    Hansen JB; Grimsgaard S; Huseby N; Sandset PM; Bønaa KH
    Thromb Res; 2001 Apr; 102(1):3-13. PubMed ID: 11323009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
    Ndonwi M; Broze G; Bajaj SP
    J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.
    Caplice NM; Mueske CS; Kleppe LS; Simari RD
    Circulation; 1998 Sep; 98(11):1051-7. PubMed ID: 9736590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
    Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapy.
    Bladbjerg EM; Larsen LF; Ostergaard P; Jespersen J
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):739-45. PubMed ID: 11132652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
    van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
    Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.